{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:44:49Z","timestamp":1791326689411,"version":"4.3.1"},"reference-count":292,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,5,1]]},"DOI":"10.1210\/er.2007-0029","type":"journal-article","created":{"date-parts":[[2008,5,14]],"date-time":"2008-05-14T16:44:32Z","timestamp":1210783472000},"page":"265-291","source":"Crossref","is-referenced-by-count":194,"title":["Neonatal Diabetes Mellitus"],"prefix":"10.1210","volume":"29","author":[{"given":"Lydia","family":"Aguilar-Bryan","sequence":"first","affiliation":[{"name":"Pacific Northwest Diabetes Research Institute, Seattle, Washington 98122"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Bryan","sequence":"additional","affiliation":[{"name":"Pacific Northwest Diabetes Research Institute, Seattle, Washington 98122"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2008,4,24]]},"reference":[{"key":"2019041122212492600_R1","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/BF01958635","article-title":"Transient and permanent neonatal diabetes.","volume":"154","author":"Fosel","year":"1995","journal-title":"Eur J Pediatr"},{"key":"2019041122212492600_R2","first-page":"32","article-title":"Neonatal diabetes.","volume":"68(Suppl 5)","author":"Kitselle","year":"2007","journal-title":"Horm Res"},{"key":"2019041122212492600_R3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1651-2227.1998.tb01394.x","article-title":"Different faces of non-autoimmune diabetes of infancy.","volume":"87","author":"Attia","year":"1998","journal-title":"Acta Paediatr"},{"key":"2019041122212492600_R4","first-page":"7","article-title":"Neonatal diabetes: new insights into aetiology and implications.","volume":"53(Suppl 1)","author":"Shield","year":"2000","journal-title":"Horm Res"},{"key":"2019041122212492600_R5","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/jmg.39.12.872","article-title":"Transient neonatal diabetes, a disorder of imprinting.","volume":"39","author":"Temple","year":"2002","journal-title":"J Med Genet"},{"key":"2019041122212492600_R6","first-page":"100","article-title":"Glycosuria of the newborn treated with insulin.","volume":"38","author":"Ramsey","year":"1926","journal-title":"Trans Am Pediatr Soc"},{"key":"2019041122212492600_R7","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/bmj.2.5302.436","article-title":"Congenital temporary diabetes mellitus.","volume":"2","author":"Hutchinson","year":"1962","journal-title":"BMJ"},{"key":"2019041122212492600_R8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0065-3101(22)00521-7","article-title":"Transient diabetes of the newborn.","volume":"16","author":"Gentz","year":"1969","journal-title":"Adv Pediatr"},{"key":"2019041122212492600_R9","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJM199509143331105","article-title":"Long-term course of neonatal diabetes.","volume":"333","author":"Muhlendahl","year":"1995","journal-title":"N Engl J Med"},{"key":"2019041122212492600_R10","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00125-002-0837-2","article-title":"Permanent diabetes mellitus in the first year of life.","volume":"45","author":"Iafusco","year":"2002","journal-title":"Diabetologia"},{"key":"2019041122212492600_R11","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s00125-006-0246-z","article-title":"Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype.","volume":"49","author":"Flanagan","year":"2006","journal-title":"Diabetologia"},{"key":"2019041122212492600_R12","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.2337\/db07-0043","article-title":"Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood.","volume":"56","author":"Flanagan","year":"2007","journal-title":"Diabetes"},{"key":"2019041122212492600_R13","doi-asserted-by":"crossref","first-page":"F39","DOI":"10.1136\/fn.76.1.F39","article-title":"Aetiopathology and genetic basis of neonatal diabetes","volume":"76","author":"Shield","year":"1997","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2019041122212492600_R14","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2337\/db06-0094","article-title":"HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6 months.","volume":"55","author":"Edghill","year":"2006","journal-title":"Diabetes"},{"key":"2019041122212492600_R15","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.2337\/diabetes.53.11.2998","article-title":"Activating mutations in the KCNJ11 gene encoding the ATP-sensitive K+ channel subunit Kir6.2 are rare in clinically defined type 1 diabetes diagnosed before 2 years.","volume":"53","author":"Edghill","year":"2004","journal-title":"Diabetes"},{"key":"2019041122212492600_R16","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.2337\/dc06-2440","article-title":"Islet-specific antibody seroconversion in patients with long duration of permanent neonatal diabetes caused by mutations in the KCNJ11 gene.","volume":"30","author":"Gach","year":"2007","journal-title":"Diabetes Care"},{"key":"2019041122212492600_R17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1172-2-12","article-title":"Neonatal diabetes mellitus: a disease linked to multiple mechanisms.","volume":"2","author":"Polak","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"2019041122212492600_R18","first-page":"193","article-title":"Neonatal diabetes mellitus\u2014genetic aspects 2004.","volume":"2","author":"Polak","year":"2004","journal-title":"Pediatr Endocrinol Rev"},{"key":"2019041122212492600_R19","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/jc.2006-2490","article-title":"Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers.","volume":"92","author":"Stanik","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122212492600_R20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1067\/mpd.2002.127089","article-title":"Neonatal diabetes mellitus: chromosomal analysis in transient and permanent cases.","volume":"141","author":"Metz","year":"2002","journal-title":"J Pediatr"},{"key":"2019041122212492600_R21","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMoa055068","article-title":"Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.","volume":"355","author":"Babenko","year":"2006","journal-title":"N Engl J Med"},{"key":"2019041122212492600_R22","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2337\/db06-1540","article-title":"New ABCC8 mutations in relapsing neonatal diabetes and clinical features.","volume":"56","author":"Vaxillaire","year":"2007","journal-title":"Diabetes"},{"key":"2019041122212492600_R23","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1210\/jc.2007-0486","article-title":"Molecular basis of neonatal diabetes in Japanese patients.","volume":"92","author":"Suzuki","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122212492600_R24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1464-5491.2007.02140.x","article-title":"The majority of cases of neonatal diabetes in Spain can be explained by known genetic abnormalities.","volume":"24","author":"Rica","year":"2007","journal-title":"Diabet Med"},{"key":"2019041122212492600_R25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20124","article-title":"KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes.","volume":"25","author":"Massa","year":"2005","journal-title":"Hum Mutat"},{"key":"2019041122212492600_R26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1210\/jcem-40-1-139","article-title":"Placental barrier to human insulin-I125 in insulin-dependent diabetic mothers.","volume":"40","author":"Kalhan","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122212492600_R27","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1073\/pnas.78.7.4588","article-title":"Transplacental passage of insulin complexed to antibody.","volume":"78","author":"Bauman","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122212492600_R28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00275654","article-title":"Insulin-anti-insulin complexes in diabetic women and their neonates","volume":"Suppl","author":"Di Mario","year":"1984","journal-title":"Diabetologia 27"},{"key":"2019041122212492600_R29","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1530\/acta.0.0160330","article-title":"Weight and length of infants of diabetic mothers.","volume":"12","author":"Pedersen","year":"1954","journal-title":"Acta Endocrinol"},{"key":"2019041122212492600_R30","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2337\/diacare.22.7.1201","article-title":"What is the significance of macrosomia?","volume":"22","author":"Schwartz","year":"1999","journal-title":"Diabetes Care"},{"key":"2019041122212492600_R31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2337\/diaspect.20.2.94","article-title":"Insulin analogs and pregnancy.","volume":"20","author":"Trujillo","year":"2007","journal-title":"Diabetes Spectrum"},{"key":"2019041122212492600_R32","first-page":"612","article-title":"Endocrine-induced forms of hypoglycemia.","volume":"136","author":"Biggemann","year":"1988","journal-title":"Monatsschr Kinderheilkd"},{"key":"2019041122212492600_R33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-2002-25315","article-title":"Antepartum findings and obstetric aspects in pregnancies followed by neonatal persistent hyperinsulinemic hypoglycemia.","volume":"19","author":"Parviainen","year":"2002","journal-title":"Am J Perinatol"},{"key":"2019041122212492600_R34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1566524013364040","article-title":"Genetics of type 2 diabetes: insight from targeted mouse mutants.","volume":"1","author":"Accili","year":"2001","journal-title":"Curr Mol Med"},{"key":"2019041122212492600_R35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJM197207202870304","article-title":"Metabolic and growth patterns in transient neonatal diabetes.","volume":"287","author":"Schiff","year":"1972","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"2019041122212492600_R36","doi-asserted-by":"crossref","first-page":"U131","DOI":"10.1530\/eje.0.151u131","article-title":"Birth weight, infant growth and insulin resistance","volume":"151","author":"Ong","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"2019041122212492600_R37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1210\/er.2006-0039","article-title":"Small for gestational age: short stature and beyond.","volume":"28","author":"Saenger","year":"2007","journal-title":"Endocr Rev"},{"key":"2019041122212492600_R38","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2796.2004.01361.x","article-title":"Low birth weight in combination with catch-up growth predicts the occurrence of the metabolic syndrome in men at late middle age: the Atherosclerosis and Insulin Resistance study.","volume":"256","author":"Fagerberg","year":"2004","journal-title":"J Intern Med"},{"key":"2019041122212492600_R39","doi-asserted-by":"crossref","first-page":"F71","DOI":"10.1136\/fn.81.1.F71","article-title":"Low birthweight and adult insulin resistance: the \u201ccatch-up growth\u201d hypothesis","volume":"81","author":"Cianfarani","year":"1999","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2019041122212492600_R40","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-2265.2006.02724.x","article-title":"Serum levels of adiponectin and IGFBP-1 in short children born small for gestational age.","volume":"66","author":"Kamoda","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041122212492600_R41","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1530\/eje.1.02337","article-title":"Serum adiponectin levels, insulin resistance, and lipid profile in children born small for gestational age are affected by the severity of growth retardation at birth.","volume":"156","author":"Evagelidou","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"2019041122212492600_R42","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.2337\/diacare.27.10.2405","article-title":"\u03b2-Cell dysfunction in classic transient neonatal diabetes is characterized by impaired insulin response to glucose but normal response to glucagon.","volume":"27","author":"Valerio","year":"2004","journal-title":"Diabetes Care"},{"key":"2019041122212492600_R43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1900\/RDS.2006.3.17","article-title":"Assessment of insulin sensitivity in adults with permanent neonatal diabetes mellitus due to mutations in the KCNJ11 gene encoding Kir6.2.","volume":"3","author":"Skupien","year":"2006","journal-title":"Rev Diabet Stud"},{"key":"2019041122212492600_R44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2337\/dc06-1628","article-title":"Transfer to sulphonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating mutations: evidence for improvement in insulin sensitivity.","volume":"30","author":"Malecki","year":"2007","journal-title":"Diabetes Care"},{"key":"2019041122212492600_R45","doi-asserted-by":"crossref","first-page":"11760","DOI":"10.1073\/pnas.201390398","article-title":"Disruption of Sur2-containing KATP channels enhances insulin-stimulated glucose uptake in skeletal muscle.","volume":"98","author":"Chutkow","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122212492600_R46","doi-asserted-by":"crossref","first-page":"E1178","DOI":"10.1152\/ajpendo.00313.2002","article-title":"ATP-sensitive potassium channels participate in glucose uptake in skeletal muscle and adipose tissue","volume":"283","author":"Miki","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041122212492600_R47","doi-asserted-by":"crossref","first-page":"F341","DOI":"10.1136\/adc.2003.030502","article-title":"An assessment of pancreatic endocrine function and insulin sensitivity in patients with transient neonatal diabetes in remission","volume":"89","author":"Shield","year":"2004","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2019041122212492600_R48","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng0394-310","article-title":"Allele specific inactivation of insulin 1 and 2, in the mouse yolk sac, indicates imprinting.","volume":"6","author":"Giddings","year":"1994","journal-title":"Nat Genet"},{"key":"2019041122212492600_R49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ng0594-10a","article-title":"Is human insulin imprinted?","volume":"7","author":"Haig","year":"1994","journal-title":"Nat Genet"},{"key":"2019041122212492600_R50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ng0295-110","article-title":"An imprinted gene(s) for diabetes?","volume":"9","author":"Temple","year":"1995","journal-title":"Nat Genet"},{"key":"2019041122212492600_R51","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/jmg.39.5.370","article-title":"Major difference in aetiology and phenotypic abnormalities between transient and permanent neonatal diabetes.","volume":"39","author":"Marquis","year":"2002","journal-title":"J Med Genet"},{"key":"2019041122212492600_R52","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1399-0004.1998.tb03774.x","article-title":"Paternal uniparental disomy of chromosome 6 and transient neonatal diabetes mellitus.","volume":"54","author":"Gardner","year":"1998","journal-title":"Clin Genet"},{"key":"2019041122212492600_R53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1542\/peds.105.1.49","article-title":"Transient but not permanent neonatal diabetes mellitus is associated with paternal uniparental isodisomy of chromosome 6.","volume":"105","author":"Hermann","year":"2000","journal-title":"Pediatrics"},{"key":"2019041122212492600_R54","first-page":"740","article-title":"Paternal uniparental isodisomy of chromosome 6 in transient neonatal diabetes mellitus.","volume":"156","author":"Hermann","year":"1997","journal-title":"Eur J Pediatr"},{"key":"2019041122212492600_R55","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/jmg.34.2.167","article-title":"Paternal uniparental disomy for chromosome 6 causes transient neonatal diabetes.","volume":"34","author":"Whiteford","year":"1997","journal-title":"J Med Genet"},{"key":"2019041122212492600_R56","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2337\/diabetes.49.1.108","article-title":"Refinement of the 6q chromosomal region implicated in transient neonatal diabetes.","volume":"49","author":"Cave","year":"2000","journal-title":"Diabetes"},{"key":"2019041122212492600_R57","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/hmg\/9.4.589","article-title":"An imprinted locus associated with transient neonatal diabetes mellitus.","volume":"9","author":"Gardner","year":"2000","journal-title":"Hum Mol Genet"},{"key":"2019041122212492600_R58","doi-asserted-by":"crossref","first-page":"8835","DOI":"10.1073\/pnas.95.15.8835","article-title":"hZAC encodes a zinc finger protein with antiproliferative properties and maps to a chromosomal region frequently lost in cancer.","volume":"95","author":"Varrault","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122212492600_R59","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1128\/MCB.23.3.988-1003.2003","article-title":"Transcriptional activities of the zinc finger protein Zac are differentially controlled by DNA binding.","volume":"23","author":"Hoffmann","year":"2003","journal-title":"Mol Cell Biol"},{"key":"2019041122212492600_R60","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1038\/sj.onc.1204298","article-title":"Enhancement of p53-dependent gene activation by the transcriptional coactivator Zac1.","volume":"20","author":"Huang","year":"2001","journal-title":"Oncogene"},{"key":"2019041122212492600_R61","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/sj.onc.1205218","article-title":"A positive feedback mechanism in the transcriptional activation of Apaf-1 by p53 and the coactivator Zac-1.","volume":"21","author":"Rozenfeld-Granot","year":"2002","journal-title":"Oncogene"},{"key":"2019041122212492600_R62","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1128\/MCB.02270-05","article-title":"Multitasking C2H2 zinc fingers link Zac DNA binding to coordinated regulation of p300-histone acetyltransferase activity.","volume":"26","author":"Hoffmann","year":"2006","journal-title":"Mol Cell Biol"},{"key":"2019041122212492600_R63","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1128\/MCB.20.5.1855-1867.2000","article-title":"Mouse Zac1, a transcriptional coactivator and repressor for nuclear receptors.","volume":"20","author":"Huang","year":"2000","journal-title":"Mol Cell Biol"},{"key":"2019041122212492600_R64","first-page":"6794","article-title":"The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas.","volume":"60","author":"Pagotto","year":"2000","journal-title":"Cancer Res"},{"key":"2019041122212492600_R65","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1038\/sj.onc.1202933","article-title":"Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors.","volume":"18","author":"Bilanges","year":"1999","journal-title":"Oncogene"},{"key":"2019041122212492600_R66","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/sj.onc.1204237","article-title":"Alternative splicing of the imprinted candidate tumor suppressor gene ZAC regulates its antiproliferative and DNA binding activities.","volume":"20","author":"Bilanges","year":"2001","journal-title":"Oncogene"},{"key":"2019041122212492600_R67","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/ijc.20971","article-title":"Epigenetic silencing of the imprinted gene ZAC by DNA methylation is an early event in the progression of human ovarian cancer.","volume":"115","author":"Kamikihara","year":"2005","journal-title":"Int J Cancer"},{"key":"2019041122212492600_R68","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1093\/emboj\/16.10.2814","article-title":"Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc finger protein expressed in the pituitary gland and the brain.","volume":"16","author":"Spengler","year":"1997","journal-title":"EMBO J"},{"key":"2019041122212492600_R69","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s001250051508","article-title":"Expression of peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) in normal human pancreatic islet cells.","volume":"43","author":"Dubois","year":"2000","journal-title":"Diabetologia"},{"key":"2019041122212492600_R70","doi-asserted-by":"crossref","first-page":"11975","DOI":"10.1158\/0008-5472.CAN-06-1529","article-title":"Peroxisome proliferator-activated receptor \u03b3 is a Zac target gene mediating Zac antiproliferation.","volume":"66","author":"Barz","year":"2006","journal-title":"Cancer Res"},{"key":"2019041122212492600_R71","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.1128\/MCB.23.20.7222-7229.2003","article-title":"Targeted elimination of peroxisome proliferator-activated receptor \u03b3 in \u03b2 cells leads to abnormalities in islet mass without compromising glucose homeostasis.","volume":"23","author":"Rosen","year":"2003","journal-title":"Mol Cell Biol"},{"issue":"Suppl 3","key":"2019041122212492600_R72","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.2337\/diabetes.53.suppl_3.S79","article-title":"Effect of PPAR-\u03b3 activation and inhibition on glucose-stimulated insulin release in INS-1e cells","volume":"53","author":"Santini","year":"2004","journal-title":"Diabetes"},{"key":"2019041122212492600_R73","doi-asserted-by":"crossref","first-page":"E390","DOI":"10.1152\/ajpendo.00016.2004","article-title":"Impact of PPAR\u03b3 overexpression and activation on pancreatic islet gene expression profile analyzed with oligonucleotide microarrays","volume":"287","author":"Parton","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041122212492600_R74","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/jmg.37.12.921","article-title":"Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome.","volume":"37","author":"Engel","year":"2000","journal-title":"J Med Genet"},{"key":"2019041122212492600_R75","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1128\/MCB.02036-06","article-title":"Allele-specific binding of CTCF to the multipartite imprinting control region KvDMR1.","volume":"27","author":"Fitzpatrick","year":"2007","journal-title":"Mol Cell Biol"},{"key":"2019041122212492600_R76","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng988","article-title":"Regional loss of imprinting and growth deficiency in mice with a targeted deletion of KvDMR1.","volume":"32","author":"Fitzpatrick","year":"2002","journal-title":"Nat Genet"},{"key":"2019041122212492600_R77","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1101\/gad.1416906","article-title":"Elongation of the Kcnq1ot1 transcript is required for genomic imprinting of neighboring genes.","volume":"20","author":"Mancini-Dinardo","year":"2006","journal-title":"Genes Dev"},{"key":"2019041122212492600_R78","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/sj.emboj.7601960","article-title":"Two distinct mechanisms of silencing by the KvDMR1 imprinting control region.","volume":"27","author":"Shin","year":"2008","journal-title":"EMBO J"},{"key":"2019041122212492600_R79","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng1096-171","article-title":"An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome.","volume":"14","author":"Hatada","year":"1996","journal-title":"Nat Genet"},{"key":"2019041122212492600_R80","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-213X-7-53","article-title":"Cdkn1c (p57Kip2) is the major regulator of embryonic growth within its imprinted domain on mouse distal chromosome 7.","volume":"7","author":"Andrews","year":"2007","journal-title":"BMC Dev Biol"},{"key":"2019041122212492600_R81","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1172\/JCI200419876","article-title":"Impaired glucose homeostasis in transgenic mice expressing the human transient neonatal diabetes mellitus locus, TNDM.","volume":"114","author":"Ma","year":"2004","journal-title":"J Clin Invest"},{"key":"2019041122212492600_R82","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.2337\/diacare.21.12.2144","article-title":"Liver and kidney function in Japanese patients with maturity-onset diabetes of the young.","volume":"21","author":"Iwasaki","year":"1998","journal-title":"Diabetes Care"},{"key":"2019041122212492600_R83","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/hmg\/8.11.2001","article-title":"A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1\u03b2.","volume":"8","author":"Lindner","year":"1999","journal-title":"Hum Mol Genet"},{"key":"2019041122212492600_R84","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1210\/jc.2003-031828","article-title":"Neonatal diabetes mellitus and neonatal polycystic, dysplastic kidneys: phenotypically discordant recurrence of a mutation in the hepatocyte nuclear factor-1\u03b2 gene due to germline mosaicism.","volume":"89","author":"Yorifuji","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122212492600_R85","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1006\/bbrc.1999.1412","article-title":"Human insulin gene is a target gene of hepatocyte nuclear factor-1\u03b1 (HNF-1\u03b1) and HNF-1\u03b2.","volume":"263","author":"Okita","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041122212492600_R86","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1172\/JCI200420083","article-title":"Mutation of hepatocyte nuclear factor-1\u03b2 inhibits Pkhd1 gene expression and produces renal cysts in mice.","volume":"113","author":"Hiesberger","year":"2004","journal-title":"J Clin Invest"},{"key":"2019041122212492600_R87","doi-asserted-by":"crossref","first-page":"20386","DOI":"10.1073\/pnas.0705957104","article-title":"Mutations of HNF-1\u03b2 inhibit epithelial morphogenesis through dysregulation of SOCS-3.","volume":"104","author":"Ma","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122212492600_R88","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1093\/nar\/gkh597","article-title":"Comprehensive search for HNF-1\u03b2-regulated genes in mouse hepatoma cells perturbed by transcription regulatory factor-targeted RNAi.","volume":"32","author":"Tanaka","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"2019041122212492600_R89","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/ng1297-384","article-title":"Mutation in hepatocyte nuclear factor-1 \u03b2 gene (TCF2) associated with MODY.","volume":"17","author":"Horikawa","year":"1997","journal-title":"Nat Genet"},{"key":"2019041122212492600_R90","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1093\/hmg\/ddh338","article-title":"HNF1\u03b2\/TCF2 mutations impair transactivation potential through altered co-regulator recruitment.","volume":"13","author":"Barbacci","year":"2004","journal-title":"Hum Mol Genet"},{"key":"2019041122212492600_R91","doi-asserted-by":"crossref","first-page":"12071","DOI":"10.1021\/bi7010527","article-title":"Structural basis of disease-causing mutations in hepatocyte nuclear factor 1\u03b2.","volume":"46","author":"Lu","year":"2007","journal-title":"Biochemistry"},{"key":"2019041122212492600_R92","doi-asserted-by":"crossref","first-page":"510","DOI":"10.7326\/0003-4819-140-7-200404060-00009","article-title":"Clinical spectrum associated with hepatocyte nuclear factor-1\u03b2 mutations.","volume":"140","author":"Bellanne-Chantelot","year":"2004","journal-title":"Ann Intern Med"},{"key":"2019041122212492600_R93","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1242\/dev.126.21.4785","article-title":"Essential role for the homeoprotein vHNF1\/HNF1\u03b2 in visceral endoderm differentiation.","volume":"126","author":"Coffinier","year":"1999","journal-title":"Development"},{"key":"2019041122212492600_R94","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1073\/pnas.0405776102","article-title":"Lack of TCF2\/vHNF1 in mice leads to pancreas agenesis.","volume":"102","author":"Haumaitre","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122212492600_R95","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/sj.emboj.7600160","article-title":"A transcriptional network in polycystic kidney disease.","volume":"23","author":"Gresh","year":"2004","journal-title":"EMBO J"},{"key":"2019041122212492600_R96","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00041552-200205000-00007","article-title":"Molecular basis of polycystic kidney disease: PKD1, PKD2 and PKHD1.","volume":"11","author":"Harris","year":"2002","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2019041122212492600_R97","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ymgme.2003.10.010","article-title":"Molecular genetics of autosomal recessive polycystic kidney disease.","volume":"81","author":"Harris","year":"2004","journal-title":"Mol Genet Metab"},{"key":"2019041122212492600_R98","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2337\/diabetes.55.01.06.db05-0681","article-title":"A vHNF1\/TCF2-HNF6 cascade regulates the transcription factor network that controls generation of pancreatic precursor cells.","volume":"55","author":"Poll","year":"2006","journal-title":"Diabetes"},{"key":"2019041122212492600_R99","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1210\/en.2004-0281","article-title":"Selective deletion of the Hnf1\u03b2 (MODY5) gene in \u03b2-cells leads to altered gene expression and defective insulin release.","volume":"145","author":"Wang","year":"2004","journal-title":"Endocrinology"},{"key":"2019041122212492600_R100","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1464-5491.2006.01999.x","article-title":"Hepatocyte nuclear factor-1 \u03b2 mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1\u03b2 in human pancreatic development.","volume":"23","author":"Edghill","year":"2006","journal-title":"Diabet Med"},{"key":"2019041122212492600_R101","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1084-2756(03)00064-2","article-title":"Neonatal and very-early-onset diabetes mellitus.","volume":"9","author":"Polak","year":"2004","journal-title":"Semin Neonatol"},{"key":"2019041122212492600_R102","first-page":"700","article-title":"Neonatal diabetes mellitus and cerebellar hypoplasia\/agenesis: report of a new recessive syndrome.","volume":"36","author":"Hoveyda","year":"1999","journal-title":"J Med Genet"},{"key":"2019041122212492600_R103","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/ng1475","article-title":"Mutations in PTF1A cause pancreatic and cerebellar agenesis.","volume":"36","author":"Sellick","year":"2004","journal-title":"Nat Genet"},{"key":"2019041122212492600_R104","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1002\/j.1460-2075.1996.tb00806.x","article-title":"The p48 DNA-binding subunit of transcription factor PTF1 is a new exocrine pancreas-specific basic helix-loop-helix protein.","volume":"15","author":"Krapp","year":"1996","journal-title":"EMBO J"},{"key":"2019041122212492600_R105","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1101\/gad.12.23.3752","article-title":"The bHLH protein PTF1\u2013p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas.","volume":"12","author":"Krapp","year":"1998","journal-title":"Genes Dev"},{"key":"2019041122212492600_R106","first-page":"1376","article-title":"Class A helix-loop-helix proteins are positive regulators of several cyclin-dependent kinase inhibitors\u2019 promoter activity and negatively affect cell growth.","volume":"60","author":"Pagliuca","year":"2000","journal-title":"Cancer Res"},{"key":"2019041122212492600_R107","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/MCB.26.1.117-130.2006","article-title":"PTF1 is an organ-specific and Notch-independent basic helix-loop-helix complex containing the mammalian Suppressor of Hairless (RBP-J) or its paralogue, RBP-L.","volume":"26","author":"Beres","year":"2006","journal-title":"Mol Cell Biol"},{"key":"2019041122212492600_R108","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuron.2005.06.007","article-title":"Ptf1a, a bHLH transcriptional gene, defines GABAergic neuronal fates in cerebellum.","volume":"47","author":"Hoshino","year":"2005","journal-title":"Neuron"},{"key":"2019041122212492600_R109","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.bbrc.2007.08.076","article-title":"Ptf1a and RBP-J cooperate in activating Pdx1 gene expression through binding to area III.","volume":"362","author":"Miyatsuka","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041122212492600_R110","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1128\/MCB.01978-06","article-title":"Ptf1a binds to and activates area III, a highly conserved region of the Pdx1 promoter that mediates early pancreas-wide Pdx1 expression.","volume":"27","author":"Wiebe","year":"2007","journal-title":"Mol Cell Biol"},{"key":"2019041122212492600_R111","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/14734220600589202","article-title":"Molecular machinery governing GABAergic neuron specification in the cerebellum.","volume":"5","author":"Hoshino","year":"2006","journal-title":"Cerebellum"},{"key":"2019041122212492600_R112","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1002\/j.1460-2075.1993.tb06109.x","article-title":"IPF1, a homeodomain-containing transactivator of the insulin gene.","volume":"12","author":"Ohlsson","year":"1993","journal-title":"EMBO J"},{"key":"2019041122212492600_R113","first-page":"789","article-title":"IPF1, a homeodomain protein with a dual function in pancreas development.","volume":"39","author":"Jonsson","year":"1995","journal-title":"Int J Dev Biol"},{"key":"2019041122212492600_R114","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/371606a0","article-title":"Insulin-promoter-factor 1 is required for pancreas development in mice.","volume":"371","author":"Jonsson","year":"1994","journal-title":"Nature"},{"key":"2019041122212492600_R115","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1210\/en.2004-1576","article-title":"Minireview: transcriptional regulation in pancreatic development.","volume":"146","author":"Habener","year":"2005","journal-title":"Endocrinology"},{"key":"2019041122212492600_R116","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s001090050118","article-title":"The \u03b2 cell transcription factors and development of the pancreas.","volume":"75","author":"Sander","year":"1997","journal-title":"J Mol Med"},{"key":"2019041122212492600_R117","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00125-004-1368-9","article-title":"Transcriptional networks controlling pancreatic development and \u03b2 cell function.","volume":"47","author":"Servitja","year":"2004","journal-title":"Diabetologia"},{"key":"2019041122212492600_R118","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.semcdb.2004.02.002","article-title":"Navigating the pathway from embryonic stem cells to \u03b2 cells.","volume":"15","author":"Stoffel","year":"2004","journal-title":"Semin Cell Dev Biol"},{"key":"2019041122212492600_R119","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMra002168","article-title":"Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young.","volume":"345","author":"Fajans","year":"2001","journal-title":"N Engl J Med"},{"key":"2019041122212492600_R120","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0197-106","article-title":"Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence.","volume":"15","author":"Stoffers","year":"1997","journal-title":"Nat Genet"},{"key":"2019041122212492600_R121","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/ng1097-138","article-title":"Early-onset type-II diabetes mellitus (MODY4) linked to IPF1.","volume":"17","author":"Stoffers","year":"1997","journal-title":"Nat Genet"},{"key":"2019041122212492600_R122","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1172\/JCI2242","article-title":"Insulin promoter factor-1 gene mutation linked to early-onset type 2 diabetes mellitus directs expression of a dominant negative isoprotein.","volume":"102","author":"Stoffers","year":"1998","journal-title":"J Clin Invest"},{"key":"2019041122212492600_R123","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1210\/jc.2003-030046","article-title":"Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1.","volume":"88","author":"Schwitzgebel","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122212492600_R124","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ajmg.a.20267","article-title":"Neonatal diabetes mellitus, congenital hypothyroidism, hepatic fibrosis, polycystic kidneys, and congenital glaucoma: a new autosomal recessive syndrome?","volume":"122","author":"Taha","year":"2003","journal-title":"Am J Med Genet A"},{"key":"2019041122212492600_R125","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ng1802","article-title":"Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism.","volume":"38","author":"Senee","year":"2006","journal-title":"Nat Genet"},{"key":"2019041122212492600_R126","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1093\/nar\/gkg776","article-title":"GLIS3, a novel member of the GLIS subfamily of Kruppel-like zinc finger proteins with repressor and activation functions.","volume":"31","author":"Kim","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"2019041122212492600_R127","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0022-3476(72)80596-1","article-title":"Infancy-onset diabetes mellitus and multiple epiphyseal dysplasia.","volume":"80","author":"Wolcott","year":"1972","journal-title":"J Pediatr"},{"key":"2019041122212492600_R128","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF00441137","article-title":"Wolcott-Rallison syndrome: diabetes mellitus and spondyloepiphyseal dysplasia.","volume":"138","author":"Sto\u0308ss","year":"1982","journal-title":"Eur J Pediatr"},{"key":"2019041122212492600_R129","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00019605-199507000-00006","article-title":"Wolcott-Rallison syndrome.","volume":"4","author":"al-Gazali","year":"1995","journal-title":"Clin Dysmorphol"},{"key":"2019041122212492600_R130","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1399-0004.1996.tb03275.x","article-title":"Wolcott-Rallison syndrome associated with congenital malformations and a mosaic deletion 15q 11\u201312.","volume":"49","author":"Stewart","year":"1996","journal-title":"Clin Genet"},{"key":"2019041122212492600_R131","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/15513819709168589","article-title":"Autopsy findings in the Wolcott-Rallison syndrome.","volume":"17","author":"Thornton","year":"1997","journal-title":"Pediatr Pathol Lab Med"},{"key":"2019041122212492600_R132","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/78085","article-title":"EIF2AK3, encoding translation initiation factor 2-\u03b1 kinase 3, is mutated in patients with Wolcott-Rallison syndrome.","volume":"25","author":"Delepine","year":"2000","journal-title":"Nat Genet"},{"key":"2019041122212492600_R133","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1074\/jbc.274.9.5723","article-title":"Characterization of a mutant pancreatic eIF-2\u03b1 kinase, PEK, and co-localization with somatostatin in islet \u03b4 cells.","volume":"274","author":"Shi","year":"1999","journal-title":"J Biol Chem"},{"key":"2019041122212492600_R134","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/16729","article-title":"Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase.","volume":"397","author":"Harding","year":"1999","journal-title":"Nature"},{"key":"2019041122212492600_R135","doi-asserted-by":"crossref","first-page":"7499","DOI":"10.1128\/MCB.18.12.7499","article-title":"Identification and characterization of pancreatic eukaryotic initiation factor 2 \u03b1-subunit kinase, PEK, involved in translational control.","volume":"18","author":"Shi","year":"1998","journal-title":"Mol Cell Biol"},{"key":"2019041122212492600_R136","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev.cellbio.21.122303.120200","article-title":"Intracellular signaling by the unfolded protein response.","volume":"22","author":"Bernales","year":"2006","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2019041122212492600_R137","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/er.2007-0015","article-title":"The role for endoplasmic reticulum stress in diabetes mellitus.","volume":"29","author":"Eizirik","year":"2007","journal-title":"Endocr Rev"},{"key":"2019041122212492600_R138","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrm2199","article-title":"Signal integration in the endoplasmic reticulum unfolded protein response.","volume":"8","author":"Ron","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2019041122212492600_R139","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev.biochem.73.011303.074134","article-title":"The mammalian unfolded protein response.","volume":"74","author":"Schroder","year":"2005","journal-title":"Annu Rev Biochem"},{"key":"2019041122212492600_R140","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0079-6603(08)60034-3","article-title":"Regulation of translational initiation during cellular responses to stress.","volume":"58","author":"Brostrom","year":"1998","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"2019041122212492600_R141"},{"key":"2019041122212492600_R142","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.2337\/diabetes.51.7.2301","article-title":"Loss of kinase activity in a patient with Wolcott-Rallison syndrome caused by a novel mutation in the EIF2AK3 gene.","volume":"51","author":"Biason-Lauber","year":"2002","journal-title":"Diabetes"},{"key":"2019041122212492600_R143","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/jmg.40.9.685","article-title":"Wolcott-Rallison syndrome: pathogenic insights into neonatal diabetes from new mutation and expression studies of EIF2AK3.","volume":"40","author":"Brickwood","year":"2003","journal-title":"J Med Genet"},{"key":"2019041122212492600_R144","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1399-0004.2006.00632.x","article-title":"A novel mutation in the EIF2AK3 gene with variable expressivity in two patients with Wolcott-Rallison syndrome.","volume":"70","author":"Durocher","year":"2006","journal-title":"Clin Genet"},{"key":"2019041122212492600_R145","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/j.1651-2227.2004.tb02748.x","article-title":"Wolcott-Rallison syndrome: a clinical and genetic study of three children, novel mutation in EIF2AK3 and a review of the literature.","volume":"93","author":"Iyer","year":"2004","journal-title":"Acta Paediatr"},{"key":"2019041122212492600_R146","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.2337\/diabetes.53.7.1876","article-title":"Wolcott-Rallison syndrome: clinical, genetic, and functional study of EIF2AK3 mutations and suggestion of genetic heterogeneity.","volume":"53","author":"Senee","year":"2004","journal-title":"Diabetes"},{"key":"2019041122212492600_R147","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1128\/MCB.22.11.3864-3874.2002","article-title":"The PERK eukaryotic initiation factor 2 \u03b1 kinase is required for the development of the skeletal system, postnatal growth, and the function and viability of the pancreas.","volume":"22","author":"Zhang","year":"2002","journal-title":"Mol Cell Biol"},{"key":"2019041122212492600_R148","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.cmet.2006.11.002","article-title":"PERK EIF2AK3 control of pancreatic \u03b2 cell differentiation and proliferation is required for postnatal glucose homeostasis.","volume":"4","author":"Zhang","year":"2006","journal-title":"Cell Metab"},{"key":"2019041122212492600_R149","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S1097-2765(01)00265-9","article-title":"Translational control is required for the unfolded protein response and in vivo glucose homeostasis.","volume":"7","author":"Scheuner","year":"2001","journal-title":"Mol Cell"},{"key":"2019041122212492600_R150","doi-asserted-by":"crossref","first-page":"15040","DOI":"10.1073\/pnas.0707291104","article-title":"Insulin gene mutations as a cause of permanent neonatal diabetes.","volume":"104","author":"St\u00f8y","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122212492600_R151","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.2337\/db07-1405","article-title":"patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood.","volume":"57","author":"Edghill","year":"1044","journal-title":"Diabetes"},{"key":"2019041122212492600_R152","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2337\/db07-1358","volume":"57","author":"Polak","journal-title":"Diabetes"},{"key":"2019041122212492600_R153","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1172\/JCI4431","article-title":"A mutation in the insulin 2 gene induces diabetes with severe pancreatic \u03b2-cell dysfunction in the Mody mouse.","volume":"103","author":"Wang","year":"1999","journal-title":"J Clin Invest"},{"key":"2019041122212492600_R154","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1172\/JCI0215020","article-title":"Proteotoxicity in the endoplasmic reticulum: lessons from the Akita diabetic mouse.","volume":"109","author":"Ron","year":"2002","journal-title":"J Clin Invest"},{"key":"2019041122212492600_R155","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.2337\/db06-0658","article-title":"Dominant-negative effects of a novel mutated Ins2 allele causes early-onset diabetes and severe \u03b2-cell loss in Munich Ins2C95S mutant mice.","volume":"56","author":"Herbach","year":"2007","journal-title":"Diabetes"},{"key":"2019041122212492600_R156","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0022-3476(82)80573-8","article-title":"An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy.","volume":"100","author":"Powell","year":"1982","journal-title":"J Pediatr"},{"key":"2019041122212492600_R157","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1086\/302761","article-title":"X-Linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23-Xq13.3.","volume":"66","author":"Bennett","year":"2000","journal-title":"Am J Hum Genet"},{"key":"2019041122212492600_R158","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1172\/JCI11679","article-title":"JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome","volume":"106","author":"Chatila","year":"2000","journal-title":"J Clin Invest"},{"key":"2019041122212492600_R159","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/83707","article-title":"X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.","volume":"27","author":"Wildin","year":"2001","journal-title":"Nat Genet"},{"key":"2019041122212492600_R160","doi-asserted-by":"crossref","first-page":"37672","DOI":"10.1074\/jbc.M104521200","article-title":"Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation.","volume":"276","author":"Schubert","year":"2001","journal-title":"J Biol Chem"},{"key":"2019041122212492600_R161","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00008480-200112000-00007","article-title":"IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena.","volume":"13","author":"Bennett","year":"2001","journal-title":"Curr Opin Pediatr"},{"key":"2019041122212492600_R162","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0925-4773(96)00539-4","article-title":"Five years on the wings of fork head.","volume":"57","author":"Kaufmann","year":"1996","journal-title":"Mech Dev"},{"key":"2019041122212492600_R163","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jmg.38.12.874","article-title":"Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX).","volume":"38","author":"Kobayashi","year":"2001","journal-title":"J Med Genet"},{"key":"2019041122212492600_R164","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archderm.140.4.466","article-title":"Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.","volume":"140","author":"Nieves","year":"2004","journal-title":"Arch Dermatol"},{"key":"2019041122212492600_R165","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ni0901-816","article-title":"Regulatory T cells in the control of immune pathology.","volume":"2","author":"Maloy","year":"2001","journal-title":"Nat Immunol"},{"key":"2019041122212492600_R166","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1073\/pnas.0501675102","article-title":"Foxp3 interacts with nuclear factor of activated T cells and NF-\u03ba B to repress cytokine gene expression and effector functions of T helper cells.","volume":"102","author":"Bettelli","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122212492600_R167","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1172\/JCI25112","article-title":"Defective regulatory and effector T cell functions in patients with FOXP3 mutations.","volume":"116","author":"Bacchetta","year":"2006","journal-title":"J Clin Invest"},{"key":"2019041122212492600_R168","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ecl.2006.02.014","article-title":"New insights in the molecular pathogenesis of the maternally inherited diabetes and deafness syndrome.","volume":"35","author":"Maassen","year":"2006","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"Suppl 1","key":"2019041122212492600_R169","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.2337\/diabetes.53.2007.S103","article-title":"Mitochondrial diabetes: molecular mechanisms and clinical presentation","volume":"53","author":"Maassen","year":"2004","journal-title":"Diabetes"},{"issue":"Suppl 3","key":"2019041122212492600_R170","doi-asserted-by":"crossref","first-page":"S394","DOI":"10.2337\/diabetes.51.2007.S394","article-title":"Regulation of pancreatic \u03b2-cell glucokinase: from basics to therapeutics","volume":"51","author":"Matschinsky","year":"2002","journal-title":"Diabetes"},{"key":"2019041122212492600_R171","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s001250051289","article-title":"Mutants of glucokinase cause hypoglycaemia- and hyperglycaemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasis.","volume":"42","author":"Davis","year":"1999","journal-title":"Diabetologia"},{"key":"2019041122212492600_R172","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11892-005-0005-4","article-title":"Glucokinase, glucose homeostasis, and diabetes mellitus.","volume":"5","author":"Matschinsky","year":"2005","journal-title":"Curr Diab Rep"},{"key":"2019041122212492600_R173","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2337\/diabetes.47.3.307","article-title":"Pancreatic \u03b2-cell glucokinase: closing the gap between theoretical concepts and experimental realities.","volume":"47","author":"Matschinsky","year":"1998","journal-title":"Diabetes"},{"key":"2019041122212492600_R174","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1042\/BST0330306","article-title":"Glucokinase and glucose homeostasis: proven concepts and new ideas.","volume":"33","author":"Zelent","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"2019041122212492600_R175","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/humu.10277","article-title":"Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.","volume":"22","author":"Gloyn","year":"2003","journal-title":"Hum Mutat"},{"key":"2019041122212492600_R176","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.2337\/diabetes.52.11.2854","article-title":"Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway.","volume":"52","author":"Njolstad","year":"2003","journal-title":"Diabetes"},{"key":"2019041122212492600_R177","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1056\/NEJM200105243442104","article-title":"Neonatal diabetes mellitus due to complete glucokinase deficiency.","volume":"344","author":"Njolstad","year":"2001","journal-title":"N Engl J Med"},{"key":"2019041122212492600_R178","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpeds.2004.09.008","article-title":"Permanent neonatal diabetes in an Asian infant.","volume":"146","author":"Porter","year":"2005","journal-title":"J Pediatr"},{"key":"2019041122212492600_R179","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.2337\/diabetes.53.8.2164","article-title":"Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation.","volume":"53","author":"Cuesta-Munoz","year":"2004","journal-title":"Diabetes"},{"key":"2019041122212492600_R180","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJM199801223380404","article-title":"Familial hyperinsulinism caused by an activating glucokinase mutation.","volume":"338","author":"Glaser","year":"1998","journal-title":"N Engl J Med"},{"key":"2019041122212492600_R181","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJM199303113281005","article-title":"Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus.","volume":"328","author":"Froguel","year":"1993","journal-title":"N Engl J Med"},{"key":"2019041122212492600_R182","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s001250051531","article-title":"MODY 2 presenting as neonatal hyperglycaemia: a need to reshape the definition of \u201cneonatal diabetes\u201d?","volume":"43","author":"Prisco","year":"2000","journal-title":"Diabetologia"},{"key":"2019041122212492600_R183","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00125-005-1731-5","article-title":"The identification of a R201H mutation in KCNJ11, which encodes Kir6.2, and successful transfer to sustained-release sulphonylurea therapy in a subject with neonatal diabetes: evidence for heterogeneity of \u03b2 cell function among carriers of the R201H mutation.","volume":"48","author":"Klupa","year":"2005","journal-title":"Diabetologia"},{"key":"2019041122212492600_R184","doi-asserted-by":"crossref","first-page":"21464","DOI":"10.1074\/jbc.270.37.21464","article-title":"Animal model for maturity-onset diabetes of the young generated by disruption of the mouse glucokinase gene.","volume":"270","author":"Bali","year":"1995","journal-title":"J Biol Chem"},{"key":"2019041122212492600_R185","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0092-8674(95)90235-X","article-title":"Transgenic knockouts reveal a critical requirement for pancreatic \u03b2 cell glucokinase in maintaining glucose homeostasis.","volume":"83","author":"Grupe","year":"1995","journal-title":"Cell"},{"key":"2019041122212492600_R186","doi-asserted-by":"crossref","first-page":"30253","DOI":"10.1074\/jbc.270.51.30253","article-title":"Pancreatic \u03b2-cell-specific targeted disruption of glucokinase gene. Diabetes mellitus due to defective insulin secretion to glucose.","volume":"270","author":"Terauchi","year":"1995","journal-title":"J Biol Chem"},{"key":"2019041122212492600_R187","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0092-8674(00)80701-1","article-title":"Targeted overactivity of \u03b2 cell KATP channels induces profound neonatal diabetes.","volume":"100","author":"Koster","year":"2000","journal-title":"Cell"},{"key":"2019041122212492600_R188","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/bbrc.1999.0172","article-title":"The N-terminus of KIR6.2 limits spontaneous bursting and modulates the ATP-inhibition of KATP channels.","volume":"255","author":"Babenko","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"issue":"Pt 1","key":"2019041122212492600_R189","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1469-7793.1999.019ad.x","article-title":"ATP inhibition of KATP channels: control of nucleotide sensitivity by the N-terminal domain of the Kir6.2 subunit","volume":"515","author":"Koster","year":"1999","journal-title":"J Physiol"},{"issue":"Pt 2","key":"2019041122212492600_R190","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1469-7793.1999.0325p.x","article-title":"Involvement of the N-terminus of Kir6.2 in coupling to the sulphonylurea receptor","volume":"518","author":"Reimann","year":"1999","journal-title":"J Physiol"},{"key":"2019041122212492600_R191","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa032922","article-title":"Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.","volume":"350","author":"Gloyn","year":"2004","journal-title":"N Engl J Med"},{"key":"2019041122212492600_R192","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2337\/diabetes.54.9.2503","article-title":"Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy.","volume":"54","author":"Hattersley","year":"2005","journal-title":"Diabetes"},{"key":"2019041122212492600_R193","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1210\/jc.2007-1826","article-title":"The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy.","volume":"93","author":"Koster","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122212492600_R194","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/ncpneuro0640","article-title":"Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11.","volume":"3","author":"Mlynarski","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"2019041122212492600_R195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1113\/jphysiol.2003.048843","article-title":"Molecular mechanism for ATP-dependent closure of the K+ channel Kir6.2.","volume":"552","author":"John","year":"2003","journal-title":"J Physiol"},{"key":"2019041122212492600_R196","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/hmg\/ddi086","article-title":"Relapsing diabetes can result from moderately activating mutations in KCNJ11.","volume":"14","author":"Gloyn","year":"2005","journal-title":"Hum Mol Genet"},{"key":"2019041122212492600_R197","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/hmg\/ddl101","article-title":"A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.","volume":"15","author":"Proks","year":"2006","journal-title":"Hum Mol Genet"},{"key":"2019041122212492600_R198","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.yjmcc.2004.12.004","article-title":"KATP channels \u201cvingt ans apres\u201d: ATG to PDB to mechanism.","volume":"39","author":"Babenko","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"2019041122212492600_R199","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0005-2736(99)00164-9","article-title":"Sulfonylurea receptors: ABC transporters that regulate ATP-sensitive K+ channels.","volume":"1461","author":"Bryan","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"2019041122212492600_R200","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00424-006-0116-z","article-title":"ABCC8 and ABCC9: ABC transporters that regulate K+ channels.","volume":"453","author":"Bryan","year":"2007","journal-title":"Pflugers Arch"},{"issue":"Suppl 3","key":"2019041122212492600_R201","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.2337\/diabetes.53.suppl_3.S104","article-title":"Toward linking structure with function in ATP-sensitive K+ channels","volume":"53","author":"Bryan","year":"2004","journal-title":"Diabetes"},{"key":"2019041122212492600_R202","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0896-6273(00)80321-9","article-title":"Association and stoichiometry of KATP channel subunits.","volume":"18","author":"Clement IV","year":"1997","journal-title":"Neuron"},{"key":"2019041122212492600_R203","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0014-5793(97)00488-2","article-title":"Subunit stoichiometry of the pancreatic \u03b2-cell ATP-sensitive K+ channel.","volume":"409","author":"Inagaki","year":"1997","journal-title":"FEBS Lett"},{"key":"2019041122212492600_R204","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1038\/sj.emboj.7600877","article-title":"3-D structural and functional characterization of the purified KATP channel complex Kir6.2-SUR1.","volume":"24","author":"Mikhailov","year":"2005","journal-title":"EMBO J"},{"key":"2019041122212492600_R205","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1085\/jgp.110.6.655","article-title":"Octameric stoichiometry of the KATP channel complex.","volume":"110","author":"Shyng","year":"1997","journal-title":"J Gen Physiol"},{"key":"2019041122212492600_R206","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1152\/physrev.1998.78.1.227","article-title":"Toward understanding the assembly and structure of KATP channels.","volume":"78","author":"Aguilar-Bryan","year":"1998","journal-title":"Physiol Rev"},{"key":"2019041122212492600_R207","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0896-6273(00)80124-5","article-title":"A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels.","volume":"16","author":"Inagaki","year":"1996","journal-title":"Neuron"},{"key":"2019041122212492600_R208","doi-asserted-by":"crossref","first-page":"24321","DOI":"10.1074\/jbc.271.40.24321","article-title":"A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K+ channel.","volume":"271","author":"Isomoto","year":"1996","journal-title":"J Biol Chem"},{"issue":"Pt 3","key":"2019041122212492600_R209","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1113\/jphysiol.1997.sp021963","article-title":"Sulphonylurea receptor 2B and Kir6.1 form a sulphonylurea-sensitive but ATP-insensitive K+ channel","volume":"499","author":"Yamada","year":"1997","journal-title":"J Physiol"},{"key":"2019041122212492600_R210","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1126\/science.7716547","article-title":"Cloning of the \u03b2 cell high-affinity sulfonylurea receptor: a regulator of insulin secretion.","volume":"268","author":"Aguilar-Bryan","year":"1995","journal-title":"Science"},{"key":"2019041122212492600_R211","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.7716548","article-title":"Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy.","volume":"268","author":"Thomas","year":"1995","journal-title":"Science"},{"key":"2019041122212492600_R212","first-page":"101","article-title":"Molecular biology of adenosine triphosphate-sensitive potassium channels.","volume":"20","author":"Aguilar-Bryan","year":"1999","journal-title":"Endocr Rev"},{"key":"2019041122212492600_R213","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1210\/rp.56.1.47","article-title":"Of mice and men: KATP channels and insulin secretion.","volume":"56","author":"Aguilar-Bryan","year":"2001","journal-title":"Recent Prog Horm Res"},{"key":"2019041122212492600_R214","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000076933","article-title":"Genetics and pathophysiology of hyperinsulinism in infancy.","volume":"61","author":"Cosgrove","year":"2004","journal-title":"Horm Res"},{"key":"2019041122212492600_R215","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1385\/EP:15:3:233","article-title":"Genetics of congenital hyperinsulinism.","volume":"15","author":"Fournet","year":"2004","journal-title":"Endocr Pathol"},{"key":"2019041122212492600_R216","first-page":"289","article-title":"Molecular mechanisms of neonatal hyperinsulinism.","volume":"66","author":"Giurgea","year":"2006","journal-title":"Horm Res"},{"key":"2019041122212492600_R217","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.siny.2005.03.001","article-title":"Congenital hyperinsulinism.","volume":"10","author":"Hussain","year":"2005","journal-title":"Semin Fetal Neonatal Med"},{"key":"2019041122212492600_R218","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.270.5239.1166","article-title":"Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor.","volume":"270","author":"Inagaki","year":"1995","journal-title":"Science"},{"key":"2019041122212492600_R219","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1146\/annurev.physiol.60.1.667","article-title":"A view of SUR\/KIR6.X, KATP channels.","volume":"60","author":"Babenko","year":"1998","journal-title":"Annu Rev Physiol"},{"key":"2019041122212492600_R220","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0896-6273(00)81146-0","article-title":"Molecular basis for KATP assembly: transmembrane interactions mediate association of a K+ channel with an ABC transporter.","volume":"26","author":"Schwappach","year":"2000","journal-title":"Neuron"},{"key":"2019041122212492600_R221","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0896-6273(00)80708-4","article-title":"A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane KATP channels.","volume":"22","author":"Zerangue","year":"1999","journal-title":"Neuron"},{"key":"2019041122212492600_R222","doi-asserted-by":"crossref","first-page":"20628","DOI":"10.1074\/jbc.274.29.20628","article-title":"The C terminus of SUR1 is required for trafficking of KATP channels.","volume":"274","author":"Sharma","year":"1999","journal-title":"J Biol Chem"},{"key":"2019041122212492600_R223","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0014-5793(99)00102-7","article-title":"Sulfonylurea receptors set the maximal open probability, ATP sensitivity and plasma membrane density of KATP channels.","volume":"445","author":"Babenko","year":"1999","journal-title":"FEBS Lett"},{"key":"2019041122212492600_R224","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/387179a0","article-title":"Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor.","volume":"387","author":"Tucker","year":"1997","journal-title":"Nature"},{"key":"2019041122212492600_R225","doi-asserted-by":"crossref","first-page":"41577","DOI":"10.1074\/jbc.C300363200","article-title":"SUR domains that associate with and gate KATP pores define a novel gatekeeper.","volume":"278","author":"Babenko","year":"2003","journal-title":"J Biol Chem"},{"key":"2019041122212492600_R226","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1093\/emboj\/cdg376","article-title":"N-terminal transmembrane domain of the SUR controls trafficking and gating of Kir6 channel subunits.","volume":"22","author":"Chan","year":"2003","journal-title":"EMBO J"},{"key":"2019041122212492600_R227","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1042\/bj20031087","article-title":"Proximal C-terminal domain of sulphonylurea receptor 2A interacts with pore-forming Kir6 subunits in KATP channels.","volume":"379","author":"Rainbow","year":"2004","journal-title":"Biochem J"},{"key":"2019041122212492600_R228","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev.biochem.73.011303.073626","article-title":"ATP-binding cassette transporters in bacteria.","volume":"73","author":"Davidson","year":"2004","journal-title":"Annu Rev Biochem"},{"key":"2019041122212492600_R229","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0896-6273(01)00356-7","article-title":"Signaling in channel\/enzyme multimers: ATPase transitions in SUR module gate ATP-sensitive K+ conductance.","volume":"31","author":"Zingman","year":"2001","journal-title":"Neuron"},{"key":"2019041122212492600_R230","doi-asserted-by":"crossref","first-page":"14206","DOI":"10.1074\/jbc.M109452200","article-title":"Tandem function of nucleotide binding domains confers competence to sulfonylurea receptor in gating ATP-sensitive K+ channels.","volume":"277","author":"Zingman","year":"2002","journal-title":"J Biol Chem"},{"key":"2019041122212492600_R231","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2337\/diabetes.49.9.1413","article-title":"ATP4\u2212 mediates closure of pancreatic \u03b2-cell ATP-sensitive potassium channels by interaction with 1 of 4 identical sites.","volume":"49","author":"Markworth","year":"2000","journal-title":"Diabetes"},{"key":"2019041122212492600_R232","doi-asserted-by":"crossref","first-page":"8778","DOI":"10.1074\/jbc.C700243200","article-title":"A novel ABCC8(SUR1)-dependent mechanism of metabolism-excitation uncoupling.","volume":"283","author":"Babenko","year":"2008","journal-title":"J Biol Chem"},{"key":"2019041122212492600_R233","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.2337\/diabetes.54.9.2645","article-title":"ATP and sulfonylurea sensitivity of mutant ATP-sensitive K+ channels in neonatal diabetes: implications for pharmacogenomic therapy.","volume":"54","author":"Koster","year":"2005","journal-title":"Diabetes"},{"key":"2019041122212492600_R234","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1093\/hmg\/ddi305","article-title":"Functional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by MgATP.","volume":"14","author":"Proks","year":"2005","journal-title":"Hum Mol Genet"},{"key":"2019041122212492600_R235","doi-asserted-by":"crossref","first-page":"17539","DOI":"10.1073\/pnas.0404756101","article-title":"Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.","volume":"101","author":"Proks","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122212492600_R236","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1113\/jphysiol.2005.099168","article-title":"Functional effects of naturally occurring KCNJ11 mutations causing neonatal diabetes on cloned cardiac KATP channels.","volume":"571","author":"Tammaro","year":"2006","journal-title":"J Physiol"},{"key":"2019041122212492600_R237","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.2337\/db05-1571","article-title":"Kir6.2 mutations associated with neonatal diabetes reduce expression of ATP-sensitive K+ channels: implications in disease mechanism and sulfonylurea therapy.","volume":"55","author":"Lin","year":"2006","journal-title":"Diabetes"},{"key":"2019041122212492600_R238","doi-asserted-by":"crossref","first-page":"10402","DOI":"10.1073\/pnas.95.18.10402","article-title":"Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice.","volume":"95","author":"Miki","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122212492600_R239","doi-asserted-by":"crossref","first-page":"9270","DOI":"10.1074\/jbc.275.13.9270","article-title":"Sur1 knockout mice. A model for KATP channel-independent regulation of insulin secretion.","volume":"275","author":"Seghers","year":"2000","journal-title":"J Biol Chem"},{"key":"2019041122212492600_R240","doi-asserted-by":"crossref","first-page":"37176","DOI":"10.1074\/jbc.M206757200","article-title":"Sulfonylurea receptor type 1 knock-out mice have intact feeding-stimulated insulin secretion despite marked impairment in their response to glucose.","volume":"277","author":"Shiota","year":"2002","journal-title":"J Biol Chem"},{"key":"2019041122212492600_R241","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12035-007-8001-0","article-title":"Ionic channel function in action potential generation: current perspective.","volume":"35","author":"Baranauskas","year":"2007","journal-title":"Mol Neurobiol"},{"key":"2019041122212492600_R242","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/14734220310015593","article-title":"What are the roles of the many different types of potassium channel expressed in cerebellar granule cells?","volume":"2","author":"Mathie","year":"2003","journal-title":"Cerebellum"},{"key":"2019041122212492600_R243","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1113\/jphysiol.2003.047175","article-title":"Gene targeting approach to clarification of ion channel function: studies of Kir6.x null mice.","volume":"554","author":"Seino","year":"2004","journal-title":"J Physiol"},{"key":"2019041122212492600_R244","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.2337\/diabetes.54.10.2946","article-title":"Serum glucagon counterregulatory hormonal response to hypoglycemia is blunted in congenital hyperinsulinism.","volume":"54","author":"Hussain","year":"2005","journal-title":"Diabetes"},{"key":"2019041122212492600_R245","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/87455","article-title":"ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis.","volume":"4","author":"Miki","year":"2001","journal-title":"Nat Neurosci"},{"key":"2019041122212492600_R246","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1210\/en.2005-0637","article-title":"Regulation of glucagon secretion at low glucose concentrations: evidence for adenosine triphosphate-sensitive potassium channel involvement.","volume":"146","author":"Munoz","year":"2005","journal-title":"Endocrinology"},{"key":"2019041122212492600_R247","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.emboj.7600487","article-title":"Functional analysis of a structural model of the ATP-binding site of the KATP channel Kir6.2 subunit.","volume":"24","author":"Antcliff","year":"2005","journal-title":"EMBO J"},{"key":"2019041122212492600_R248","doi-asserted-by":"crossref","first-page":"18988","DOI":"10.1073\/pnas.0707428104","article-title":"Increased ATPase activity produced by mutations at arginine-1380 in nucleotide-binding domain 2 of ABCC8 causes neonatal diabetes.","volume":"104","author":"Wet","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122212492600_R249","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1210\/jc.2005-0096","article-title":"The C42R mutation in the Kir6.2 (KCNJ11) gene as a cause of transient neonatal diabetes, childhood diabetes, or later-onset, apparently type 2 diabetes mellitus.","volume":"90","author":"Yorifuji","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122212492600_R250","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1126\/science.282.5391.1141","article-title":"PIP2 and PIP as determinants for ATP inhibition of KATP channels.","volume":"282","author":"Baukrowitz","year":"1998","journal-title":"Science"},{"key":"2019041122212492600_R251","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1085\/jgp.114.2.251","article-title":"Phosphoinositides decrease ATP sensitivity of the cardiac ATP-sensitive K+ channel. A molecular probe for the mechanism of ATP-sensitive inhibition.","volume":"114","author":"Fan","year":"1999","journal-title":"J Gen Physiol"},{"key":"2019041122212492600_R252","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1126\/science.282.5391.1138","article-title":"Membrane phospholipid control of nucleotide sensitivity of KATP channels.","volume":"282","author":"Shyng","year":"1998","journal-title":"Science"},{"key":"2019041122212492600_R253","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1046\/j.1432-1327.2000.01672.x","article-title":"KATP channels gated by intracellular nucleotides and phospholipids.","volume":"267","author":"Baukrowitz","year":"2000","journal-title":"Eur J Biochem"},{"key":"2019041122212492600_R254","doi-asserted-by":"crossref","first-page":"17390","DOI":"10.1074\/jbc.272.28.17390","article-title":"Evidence for a unique long chain acyl-CoA ester binding site on the ATP-regulated potassium channel in mouse pancreatic \u03b2 cells.","volume":"272","author":"Branstrom","year":"1997","journal-title":"J Biol Chem"},{"key":"2019041122212492600_R255","doi-asserted-by":"crossref","first-page":"26383","DOI":"10.1074\/jbc.273.41.26383","article-title":"Mechanism of cloned ATP-sensitive potassium channel activation by oleoyl-CoA.","volume":"273","author":"Gribble","year":"1998","journal-title":"J Biol Chem"},{"key":"2019041122212492600_R256","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.2337\/diabetes.52.10.2630","article-title":"Kir6.2 polymorphisms sensitize \u03b2-cell ATP-sensitive potassium channels to activation by acyl CoAs: a possible cellular mechanism for increased susceptibility to type 2 diabetes?","volume":"52","author":"Riedel","year":"2003","journal-title":"Diabetes"},{"key":"2019041122212492600_R257","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00439-004-1216-5","article-title":"Current status of the E23K Kir6.2 polymorphism: implications for type-2 diabetes.","volume":"116","author":"Riedel","year":"2005","journal-title":"Hum Genet"},{"key":"2019041122212492600_R258","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archpedi.1979.02130010071012","article-title":"Transient neonatal diabetes mellitus. Treatment with chlorpropamide.","volume":"133","author":"Kuna","year":"1979","journal-title":"Am J Dis Child"},{"key":"2019041122212492600_R259","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/000992288802700508","article-title":"Neonatal diabetes mellitus in first cousins.","volume":"27","author":"Mathew","year":"1988","journal-title":"Clin Pediatr (Phila)"},{"key":"2019041122212492600_R260","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1651-2227.1989.tb11114.x","article-title":"Transient neonatal diabetes mellitus in a pair of twins.","volume":"78","author":"Nielsen","year":"1989","journal-title":"Acta Paediatr Scand"},{"key":"2019041122212492600_R261","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1399-5448.2007.00231.x","article-title":"Transition from insulin to glyburide in a 4-month-old girl with neonatal diabetes mellitus caused by a mutation in KCNJ11.","volume":"8","author":"Chan","year":"2007","journal-title":"Pediatr Diabetes"},{"key":"2019041122212492600_R262","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.2337\/dc06-2134","article-title":"Sulfonylurea treatment in young children with neonatal diabetes: dealing with hyperglycemia, hypoglycemia, and sick days","volume":"30","author":"Codner","year":"2007","journal-title":"Diabetes Care"},{"key":"2019041122212492600_R263","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s00125-005-1958-1","article-title":"Transient neonatal diabetes mellitus is associated with a recurrent (R201H) KCNJ11 (KIR6.2) mutation.","volume":"48","author":"Colombo","year":"2005","journal-title":"Diabetologia"},{"key":"2019041122212492600_R264","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.2337\/dc07-1196","article-title":"Sulfonylrea treatment in permanent neonatal diabetes due to G53D mutation in the KCNJ11 gene: improvement in glycemic control and neurological function","volume":"30","author":"Gurgel","year":"2007","journal-title":"Diabetes Care"},{"key":"2019041122212492600_R265","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3346\/jkms.2007.22.4.616","article-title":"Sulfonylurea therapy in two Korean patients with insulin-treated neonatal diabetes due to heterozygous mutations of the KCNJ11 gene encoding Kir6.2.","volume":"22","author":"Kim","year":"2007","journal-title":"J Korean Med Sci"},{"key":"2019041122212492600_R266","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2337\/db06-1275","article-title":"An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes.","volume":"56","author":"Masia","year":"2007","journal-title":"Diabetes"},{"key":"2019041122212492600_R267","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2337\/diabetes.53.10.2713","article-title":"Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy.","volume":"53","author":"Sagen","year":"2004","journal-title":"Diabetes"},{"key":"2019041122212492600_R268","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1212\/01.wnl.0000268488.51776.53","article-title":"A novel mutation causing DEND syndrome.","volume":"69","author":"Shimomura","year":"2007","journal-title":"Neurology"},{"key":"2019041122212492600_R269","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1007\/s00125-006-0407-0","article-title":"Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene.","volume":"49","author":"Slingerland","year":"2006","journal-title":"Diabetologia"},{"key":"2019041122212492600_R270","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1007\/s00125-006-0329-x","article-title":"Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene.","volume":"49","author":"Tonini","year":"2006","journal-title":"Diabetologia"},{"key":"2019041122212492600_R271","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1210\/jc.2004-1241","article-title":"Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2.","volume":"89","author":"Zung","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122212492600_R272","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJMoa061759","article-title":"Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.","volume":"355","author":"Pearson","year":"2006","journal-title":"N Engl J Med"},{"key":"2019041122212492600_R273","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2337\/dc07-1785","article-title":"Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations.","volume":"31","author":"Rafiq","year":"2008","journal-title":"Diabetes Care"},{"key":"2019041122212492600_R274","first-page":"S108","article-title":"Uptake and efflux transport mechanisms of tolbutamide across the blood-brain barrier","volume":"14","author":"Koyabu","year":"1999","journal-title":"In: Xenobiotic metabolism and disposition. Xenobiotic Metab Disp"},{"key":"2019041122212492600_R275","first-page":"665","article-title":"[Current percentile curves for body weight, body length and head circumference of newborn infants after the 25th week of pregnancy].","volume":"141","author":"Weller","year":"1993","journal-title":"Monatsschr Kinderheilkd"},{"key":"2019041122212492600_R276","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s00424-002-0975-x","article-title":"Phosphocreatine as a determinant of KATP channel activity in pancreatic \u03b2-cells.","volume":"445","author":"Krippeit-Drews","year":"2003","journal-title":"Pflugers Arch"},{"key":"2019041122212492600_R277","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1007\/s00125-007-0742-9","article-title":"An adenylate kinase is involved in KATP channel regulation of mouse pancreatic \u03b2 cells.","volume":"50","author":"Schulze","year":"2007","journal-title":"Diabetologia"},{"key":"2019041122212492600_R278","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1086\/519174","article-title":"Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects.","volume":"81","author":"Ellard","year":"2007","journal-title":"Am J Hum Genet"},{"key":"2019041122212492600_R279","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00424-006-0112-3","article-title":"Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes.","volume":"453","author":"Girard","year":"2006","journal-title":"Pflugers Arch"},{"key":"2019041122212492600_R280","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.2337\/db05-1420","article-title":"Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy.","volume":"55","author":"Proks","year":"2006","journal-title":"Diabetes"},{"key":"2019041122212492600_R281","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/sj.embor.7400393","article-title":"A gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndrome.","volume":"6","author":"Proks","year":"2005","journal-title":"EMBO Rep"},{"key":"2019041122212492600_R282","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.2337\/db05-1640","article-title":"Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects.","volume":"55","author":"Shimomura","year":"2006","journal-title":"Diabetes"},{"key":"2019041122212492600_R283","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2337\/db07-0999","article-title":"Mosaic paternal uniparental isodisomy and an ABCC8 gene mutation in a patient with permanent neonatal diabetes and hemihypertrophy.","volume":"57","author":"Shield","year":"2008","journal-title":"Diabetes"},{"key":"2019041122212492600_R284","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1113\/jphysiol.2007.130211","article-title":"The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits.","volume":"581","author":"Tammaro","year":"2007","journal-title":"J Physiol"},{"key":"2019041122212492600_R285","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.emboj.7600715","article-title":"Kir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2-SUR1 interactions.","volume":"24","author":"Tammaro","year":"2005","journal-title":"EMBO J"},{"key":"2019041122212492600_R286","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1463-1326.2007.00777.x","article-title":"Functional analysis of two Kir6.2 (KCNJ11) mutations, K170T and E322K, causing neonatal diabetes.","volume":"9(Suppl 2)","author":"Tarasov","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"2019041122212492600_R287","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1038\/sj.emboj.7601828","article-title":"Crystal structure of a Kir3.1-prokaryotic Kir channel chimera.","volume":"26","author":"Nishida","year":"2007","journal-title":"EMBO J"},{"key":"2019041122212492600_R288","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.febslet.2007.01.073","article-title":"Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP-PNP.","volume":"581","author":"Dawson","year":"2007","journal-title":"FEBS Lett"},{"key":"2019041122212492600_R289","doi-asserted-by":"crossref","first-page":"19005","DOI":"10.1073\/pnas.0709388104","article-title":"Flexibility in the ABC transporter MsbA: alternating access with a twist.","volume":"104","author":"Ward","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122212492600_R290","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis.","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"2019041122212492600_R291","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/07853890510007287","article-title":"Mutations in the Kir6.2 subunit of the KATP channel and permanent neonatal diabetes: new insights and new treatment.","volume":"37","author":"Slingerland","year":"2005","journal-title":"Ann Med"},{"key":"2019041122212492600_R292","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jpeds.2007.03.004","article-title":"Sulfonylurea-responsive diabetes in childhood.","volume":"150","author":"Landau","year":"2007","journal-title":"J Pediatr"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/29\/3\/265\/8862309\/edrv0265.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T10:03:07Z","timestamp":1684404187000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/29\/3\/265\/2354971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,24]]},"references-count":292,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,4,24]]},"published-print":{"date-parts":[[2008,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2007-0029","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,24]]}}}